Biotechnology

Propanc Biopharma

Propanc Biopharma released FY2026 Q1 earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.3923

Propanc Biopharma Reports Q3 2025 Earnings

Propanc Biopharma released FY2025 Q4 earnings on September 29 (EST), actual revenue USD 0, actual EPS USD -0.3506

Propanc Biopharma released FY2025 Annual Earnings on September 29 (EST), Actual Revenue: USD 0, Actual EPS: USD -14.8489

Propanc Biopharma plans to acquire $100 million in Ethereum

Propanc Biopharma, Inc. released FY2025 Q3 earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD -12.4982

Propanc Biopharma, Inc. released FY2025 9 Months earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD -44.73

Propanc Biopharma, Inc. released FY2025 Q2 earnings on February 14, 2025 (EST) with actual revenue of 0 USD and EPS of -32.2306 USD

Propanc Biopharma, Inc. released FY2025 Semi-Annual Earnings on February 14 (EST) with actual revenue of 0 USD and EPS of -67.6462 USD

Propanc Biopharma, Inc. released FY2025 Q1 earnings on November 14 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2024 Q4 earnings on September 30 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2024 Annual Earnings on September 30 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2024 9 Months Earnings on May 15 (EST) with actual revenue of USD 0 and EPS of USD 0

Propanc Biopharma released FY2024 Q3 earnings on May 15 (EST), actual revenue USD 0, actual EPS USD 0

Propanc Biopharma, Inc. released FY2024 Semi-Annual Earnings on February 20, 2024 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2024 Q2 earnings on February 20, 2024 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2024 Q1 earnings on November 14 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2023 Annual Earnings on September 28 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2023 Q4 earnings on September 28 (EST) with actual revenue of 0 USD and EPS of 0 USD

Propanc Biopharma, Inc. released FY2023 Q3 earnings on May 15 (EST) with actual revenue of 0 USD and EPS of 0 USD

Luminar Tech

Novabay Pharmac

Mint Incorporation

Autozi Internet Tech Global

GD Culture

Impact BioMedical

Tradr 2X Long FLY Daily ETF

Leverage Shares 2X Long CRWV Daily ETF

T-REX 2X Long CRWV Daily Target ETF

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap